Public research preview

Gilbert Cisneros, Representative disclosure: 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Disclosed a sell transaction in 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Vær forsigtig med at jage
49/100
Signalkvalitet
34/100
Datakvalitet
93%
Høj kvalitet

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
4 Sept 2026, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
36 days

Tidslinje

Transaktionsdato

30 Jul 2026

Offentliggørelse

4 Sept 2026

Nu

Sporet i dag

Indberetningsforsinkelse: 36 dage

Kursbevægelse

Delvis dækning

Udbyder
Yahoo Finance daily close
Hentet
8. sep. 2026

Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.

Kursforløb

CRNX fra kontekst før transaktionen til seneste lukkekurs.

Seneste

2. sep. 2026 · 84,95 USD · Endnu ikke offentlig

Systemets beslutning

Ville ikke købeStrategiens filtre afviser dette signal. Fejlede filtre: Buy disclosure · Filed within 30 days · Pre-disclosure move <= 35%.

Endnu ikke offentlig84,884,984,9USDDato20. aug.24. aug.2. sep.Officiel offentliggørelse4. sep.Seneste
  • Endnu ikke offentlig
  • Ville ikke købe
Fallbackkurs ved transaktion
Fallbackkurs ved offentliggørelse
Seneste fallbackkurs
Bevægelse før indberetning
Bevægelse efter indberetning
Markedsjusteret bevægelse
1w since disclosure
1m since disclosure
3m since disclosure
Topstigning før indberetning
+0,2 %
Tilbagetrækning fra top
0,0 %

Why Copy Window is Be careful chasing

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is currently treated as 0% because market-price coverage is unavailable.

Cautions

  • Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.
  • Copy Window is using a transaction-price fallback until coverage improves.
  • Price coverage is partial; accepted for official-source intake before market data enrichment.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 4 Sept 2026, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value15001
sourcehouse_stock_act
tickerCRNX
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035190.pdf
personNameGilbert Cisneros
amountRange$15,001 - $50,000
companyNameCrinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
publishedAt2026-09-04T00:00:00.000Z
rawDocumentIdraw-us-house-20035190-16
disclosureDate2026-09-04
transactionDate2026-07-30
transactionTypeS